| HCC (n = 94) | Liver metastasis (n = 14) |
---|---|---|
Age, yearsa | 69 (65–87) | 60 (21–85) |
Gender (male/female) | 70/24 | 10/4 |
Plt (×103/μl)a | 14.2 (3.1–34.6) | 27.8 (81–195) |
BMI (kg/m2)a | 21.5 (18.5–33.5) | 21.7 (19.0–27.5) |
Alb (g/dl)a | 4.1 (2.8–5.1) | 4.4 (3.4–4.8) |
T-Bil (mg/dl)a | 0.7 (0.3–2.9) | 0.8 (0.5–2.1) |
AST (U/L)a | 36.5 (13–114) | 19 (14–62) |
ALT (U/L)a | 30.9 (9–114) | 16 (10–61) |
M2BPGi (COI))a | 2.79 (0.29–8.75) | 0.55 (0.29–3.89) |
FIB-4 indexa | 4.27 (0.3–13.7) | 2.14 (0.34–1.42) |
SVR/non-SVR | 30/64 | – |
Fibrosis (F:0–1/2/3/4) | (2/36/39/17) | (14/0/0/0) |
Inflammation (A:0/1/2/3) | (0/17/60/17) | (14/0/0/0) |
FibroScan (kPa)a | 13.9 (2.5–46.4) | 5.1 (2.5–8.3) |
VTQ (m/s)a | 1.79 (0.89–3.45) | 1.23 (0.96–1.47) |
HCC Stage (I/II/III) | (48/35/11) | – |